Exagen Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
XGN on Nasdaq
Location
1261 Liberty Way, Vista, CA

Insiders trading volume in the past year

Exagen Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
NMSIC Co-Investment Fund, L.P. 10%+ Owner $6.96M -$660K -8.66% Nov 20, 2024
L. Tullis James 10%+ Owner $2.69M Jun 15, 2023
John Aballi President and CEO, Director $1.94M +$146K +8.14% Nov 14, 2024
Jeffrey G. Black Chief Financial Officer $818K +$66.4K +8.84% Nov 15, 2024
Kamal Adawi CFO and Corporate Secretary $466K -$37.5K -7.46% Mar 4, 2024
Mark Hazeltine Chief Business Officer $332K Mar 2, 2023
Fortunato R. Rocca President and CEO, Director $211K Mar 1, 2022
Debra Zack Chief Medical Officer $147K Mar 1, 2022
Ana Hooker Director Jun 10, 2024
Ebetuel Pallares Director Jun 9, 2023
Frank Stokes Director Jun 10, 2024
Brian Birk Director Jun 9, 2023
Wendy S. Johnson Director Jun 9, 2023
Bruce C. Robertson Director Jun 17, 2021
Tina Susan Nova Director Jun 10, 2024
Paul Kim Director Jun 10, 2024
Scott D. Kahn Director Jun 10, 2024

Recent Insider Transactions by Companies or Individuals for Exagen Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.